» Articles » PMID: 18206807

Endothelial Progenitor Cells for Cardiovascular Regeneration

Overview
Date 2008 Jan 22
PMID 18206807
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial progenitor cells (EPCs) are peripheral blood mononuclear cells that can differentiate into mature endothelial cells. Adult EPCs were first discovered in human peripheral blood in 1997. Since then, the potency of EPCs for cardiovascular regeneration has been demonstrated in several preclinical studies; and investigators are beginning to evaluate the therapeutic utility of EPCs in early-phase clinical trials. This review summarizes the progression of basic, preclinical, and clinical research into the potential use of EPC therapy for cardiovascular regeneration.

Citing Articles

Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review).

Li J, Zhao Y, Zhu W Exp Ther Med. 2021; 23(1):64.

PMID: 34934435 PMC: 8649855. DOI: 10.3892/etm.2021.10986.


Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges.

Parrotta E, Lucchino V, Scaramuzzino L, Scalise S, Cuda G Int J Mol Sci. 2020; 21(12).

PMID: 32575374 PMC: 7352327. DOI: 10.3390/ijms21124354.


MicroRNA-126 protects against vascular injury by promoting homing and maintaining stemness of late outgrowth endothelial progenitor cells.

Pei C, Liu B, Li Y, Fang L, Zhang Y, Li Y Stem Cell Res Ther. 2020; 11(1):28.

PMID: 31964421 PMC: 6975061. DOI: 10.1186/s13287-020-1554-9.


Inhibition of Galectin-3 Alleviates Cigarette Smoke Extract-Induced Autophagy and Dysfunction in Endothelial Progenitor Cells.

Pei C, Wang X, Lin Y, Fang L, Meng S Oxid Med Cell Longev. 2019; 2019:7252943.

PMID: 31737173 PMC: 6815545. DOI: 10.1155/2019/7252943.


Radio-detoxified LPS alters bone marrow-derived extracellular vesicles and endothelial progenitor cells.

Hegyesi H, Sandor N, Safrany G, Lovas V, Kovacs A, Takacs A Stem Cell Res Ther. 2019; 10(1):313.

PMID: 31665090 PMC: 6819448. DOI: 10.1186/s13287-019-1417-4.


References
1.
Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M . CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006; 114(20):2163-9. DOI: 10.1161/CIRCULATIONAHA.106.644518. View

2.
Peichev M, Naiyer A, Pereira D, Zhu Z, Lane W, Williams M . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000; 95(3):952-8. View

3.
Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet P, Windecker S . Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 2001; 104(17):2012-7. DOI: 10.1161/hc4201.097835. View

4.
Lin Y, Weisdorf D, Solovey A, Hebbel R . Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000; 105(1):71-7. PMC: 382587. DOI: 10.1172/JCI8071. View

5.
Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S . Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res. 2006; 98(9):1194-202. DOI: 10.1161/01.RES.0000219901.13974.15. View